These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 30871063)

  • 1. Transcriptomic Landscape of Cisplatin-Resistant Neuroblastoma Cells.
    Rodrigo MAM; Buchtelova H; Jimenez AMJ; Adam P; Babula P; Heger Z; Adam V
    Cells; 2019 Mar; 8(3):. PubMed ID: 30871063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic Signature of Neuroblastoma Cells UKF-NB-4 Reveals Key Role of Lysosomal Sequestration and the Proteasome Complex in Acquiring Chemoresistance to Cisplatin.
    Merlos Rodrigo MA; Buchtelova H; de Los Rios V; Casal JI; Eckschlager T; Hrabeta J; Belhajova M; Heger Z; Adam V
    J Proteome Res; 2019 Mar; 18(3):1255-1263. PubMed ID: 30592607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valproic acid inhibits adhesion of vincristine- and cisplatin-resistant neuroblastoma tumour cells to endothelium.
    Blaheta RA; Michaelis M; Natsheh I; Hasenberg C; Weich E; Relja B; Jonas D; Doerr HW; Cinatl J
    Br J Cancer; 2007 Jun; 96(11):1699-706. PubMed ID: 17505515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of drug-resistant neuroblastoma cell lines by comparative genomic hybridization.
    Bedrnicek J; Vicha A; Jarosova M; Holzerova M; Cinatl J; Michaelis M; Cinatl J; Eckschlager T
    Neoplasma; 2005; 52(5):415-9. PubMed ID: 16151587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Identifying the Importance of MT-3 Expression for Neuroblastoma Cells].
    Eckschlager T; Vícha A; Jenčová P; Merlos R; Dostálová S; Buchtelová H; Strmiska V; Michálek P; Heger Z; Adam V
    Klin Onkol; 2018; 31(Supplementum1):145-147. PubMed ID: 29808689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vacuolar-ATPase-mediated intracellular sequestration of ellipticine contributes to drug resistance in neuroblastoma cells.
    Hrabeta J; Groh T; Khalil MA; Poljakova J; Adam V; Kizek R; Uhlik J; Doktorova H; Cerna T; Frei E; Stiborova M; Eckschlager T
    Int J Oncol; 2015 Sep; 47(3):971-80. PubMed ID: 26134421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of resistance to vincristine and doxorubicin in neuroblastoma alters malignant properties and induces additional karyotype changes: a preclinical model.
    Kotchetkov R; Cinatl J; Blaheta R; Vogel JU; Karaskova J; Squire J; Hernáiz Driever P; Klingebiel T; Cinatl J
    Int J Cancer; 2003 Mar; 104(1):36-43. PubMed ID: 12532417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metallothionein-3 promotes cisplatin chemoresistance remodelling in neuroblastoma.
    Rodrigo MAM; Michalkova H; Strmiska V; Casar B; Crespo P; de Los Rios V; Ignacio Casal J; Haddad Y; Guran R; Eckschlager T; Pokorna P; Heger Z; Adam V
    Sci Rep; 2021 Mar; 11(1):5496. PubMed ID: 33750814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cisplatin-resistant neuroblastoma cells express enhanced levels of epidermal growth factor receptor (EGFR) and are sensitive to treatment with EGFR-specific toxins.
    Michaelis M; Bliss J; Arnold SC; Hinsch N; Rothweiler F; Deubzer HE; Witt O; Langer K; Doerr HW; Wels WS; Cinatl J
    Clin Cancer Res; 2008 Oct; 14(20):6531-7. PubMed ID: 18927293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DFF45/ICAD restores cisplatin-induced nuclear fragmentation but not DNA cleavage in DFF45-deficient neuroblastoma cells.
    Takahashi M; Ozaki T; Takahashi A; Miyauchi M; Ono S; Takada N; Koda T; Todo S; Kamijo T; Nakagawara A
    Oncogene; 2007 Aug; 26(38):5669-73. PubMed ID: 17353905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional and transcriptomic characterization of cisplatin-resistant AGS and MKN-28 gastric cancer cell lines.
    Mora-Lagos B; Cartas-Espinel I; Riquelme I; Parker AC; Piccolo SR; Viscarra T; Reyes ME; Zanella L; Buchegger K; Ili C; Brebi P
    PLoS One; 2020; 15(1):e0228331. PubMed ID: 31990955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systems biology approach to identify microRNAs contributing to cisplatin resistance in human ovarian cancer cells.
    Liu W; Wang S; Zhou S; Yang F; Jiang W; Zhang Q; Wang L
    Mol Biosyst; 2017 Oct; 13(11):2268-2276. PubMed ID: 28861582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA HOXA11-AS Promotes Proliferation and Cisplatin Resistance of Oral Squamous Cell Carcinoma by Suppression of miR-214-3p Expression.
    Wang X; Li H; Shi J
    Biomed Res Int; 2019; 2019():8645153. PubMed ID: 31275988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene Expression Signature of Acquired Chemoresistance in Neuroblastoma Cells.
    Jemaà M; Sime W; Abassi Y; Lasorsa VA; Bonne Køhler J; Michaelis M; Cinatl J; Capasso M; Massoumi R
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32948088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tubeimoside I sensitizes cisplatin in cisplatin-resistant human ovarian cancer cells (A2780/DDP) through down-regulation of ERK and up-regulation of p38 signaling pathways.
    Liu HZ; Yu C; Yang Z; He JL; Chen WJ; Yin J; Li WM; Liu HT; Wang YX
    Mol Med Rep; 2011; 4(5):985-92. PubMed ID: 21687949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased HRD score in cisplatin resistant penile cancer cells.
    Winkelmann R; Bankov K; Döring C; Cinatl J; Grothe S; Rothweiler F; Michaelis M; Schmitt C; Wild PJ; Demes M; Cinatl J; Vallo S
    BMC Cancer; 2022 Dec; 22(1):1352. PubMed ID: 36564761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human neuroblastoma cells with acquired resistance to the p53 activator RITA retain functional p53 and sensitivity to other p53 activating agents.
    Michaelis M; Rothweiler F; Agha B; Barth S; Voges Y; Löschmann N; von Deimling A; Breitling R; Doerr HW; Rödel F; Speidel D; Cinatl J
    Cell Death Dis; 2012 Apr; 3(4):e294. PubMed ID: 22476102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chloroquine reverses chemoresistance via upregulation of p21
    Hwang JR; Kim WY; Cho YJ; Ryu JY; Choi JJ; Jeong SY; Kim MS; Kim JH; Paik ES; Lee YY; Han HD; Lee JW
    Cell Death Dis; 2020 Dec; 11(12):1034. PubMed ID: 33277461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor activity of the selective MDM2 antagonist nutlin-3 against chemoresistant neuroblastoma with wild-type p53.
    Van Maerken T; Ferdinande L; Taildeman J; Lambertz I; Yigit N; Vercruysse L; Rihani A; Michaelis M; Cinatl J; Cuvelier CA; Marine JC; De Paepe A; Bracke M; Speleman F; Vandesompele J
    J Natl Cancer Inst; 2009 Nov; 101(22):1562-74. PubMed ID: 19903807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoresistance induces enhanced adhesion and transendothelial penetration of neuroblastoma cells by down-regulating NCAM surface expression.
    Blaheta RA; Daher FH; Michaelis M; Hasenberg C; Weich EM; Jonas D; Kotchetkov R; Doerr HW; Cinatl J
    BMC Cancer; 2006 Dec; 6():294. PubMed ID: 17181871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.